Dr. Michael Tharp, MD

NPI: 1699785295
Total Payments
$22,861
2024 Payments
$30.18
Companies
13
Transactions
36
Medicare Patients
1,582
Medicare Billing
$112,431

Payment Breakdown by Category

Consulting$13,600 (59.5%)
Research$7,788 (34.1%)
Food & Beverage$839.42 (3.7%)
Travel$604.47 (2.6%)
Education$29.00 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $13,600 6 59.5%
Unspecified $7,788 7 34.1%
Food and Beverage $839.42 20 3.7%
Travel and Lodging $604.47 2 2.6%
Education $29.00 1 0.1%

Payments by Type

General
$15,073
29 transactions
Research
$7,788
7 transactions

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $12,858 8 $0 (2021)
Genentech USA, Inc. $4,864 4 $0 (2017)
E.R. Squibb & Sons, L.L.C. $2,910 2 $0 (2022)
Merck Sharp & Dohme Corporation $1,300 2 $0 (2018)
PFIZER INC. $395.66 2 $0 (2022)
Ortho Dermatologics, a division of Bausch Health US, LLC $180.60 2 $0 (2018)
Boston Scientific Corporation $179.55 8 $0 (2024)
ABBVIE INC. $42.33 2 $0 (2022)
DUSA Pharmaceuticals, Inc. $38.80 2 $0 (2019)
Janssen Scientific Affairs, LLC $29.47 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $30.18 1 Boston Scientific Corporation ($30.18)
2022 $3,366 9 E.R. Squibb & Sons, L.L.C. ($2,910)
2021 $5,477 5 Novartis Pharmaceuticals Corporation ($5,400)
2020 $14.62 1 Boston Scientific Corporation ($14.62)
2019 $39.30 2 Boston Scientific Corporation ($23.05)
2018 $7,837 10 NOVARTIS PHARMACEUTICALS CORPORATION ($7,131)
2017 $6,097 8 Genentech USA, Inc. ($4,864)

All Payment Transactions

36 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
05/06/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $30.18 General
Category: General - Vascular Intervention_PI
12/17/2022 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $31.17 General
Category: WATCHMAN_IC
11/25/2022 E.R. Squibb & Sons, L.L.C. Consulting Fee Cash or cash equivalent $2,900.00 General
11/02/2022 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $18.65 General
Category: WATCHMAN_IC
09/16/2022 Boston Scientific Corporation General - Metallic Stents (Device) Food and Beverage In-kind items and services $19.60 General
Category: General - Metallic Stents_PI
09/02/2022 PFIZER INC. EUCRISA (Drug) In-kind items and services $330.00 Research
Study: CRISABOROLE CLINICAL PUBLICATION PROGRAM • Category: DERMATOLOGY
08/12/2022 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $23.21 General
Category: WATCHMAN_IC
05/02/2022 Boston Scientific Corporation WATCHMAN Access System (Device) Food and Beverage In-kind items and services $19.07 General
Category: WATCHMAN_IC
03/30/2022 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $14.62 General
Category: IMMUNOLOGY
03/25/2022 E.R. Squibb & Sons, L.L.C. Food and Beverage Cash or cash equivalent $9.95 General
11/19/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Consulting Fee Cash or cash equivalent $2,880.00 General
Category: IMMUNOLOGY
10/06/2021 SANOFI-AVENTIS U.S. LLC Education In-kind items and services $29.00 General
08/07/2021 Janssen Scientific Affairs, LLC TREMFYA (Drug) Food and Beverage In-kind items and services $29.47 General
Category: Immunology
08/07/2021 Incyte Corporation Food and Beverage Cash or cash equivalent $18.66 General
07/17/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Consulting Fee Cash or cash equivalent $2,520.00 General
Category: IMMUNOLOGY
02/10/2020 Boston Scientific Corporation GENERAL - ATHERECTOMY (Device) Food and Beverage In-kind items and services $14.62 General
Category: ATHERECTOMY
11/25/2019 DUSA Pharmaceuticals, Inc. ODOMZO (Drug), BLU-U, LEVULAN KERASTICK Food and Beverage Cash or cash equivalent $16.25 General
Category: Oncology
03/14/2019 Boston Scientific Corporation GENERAL VASCULAR INTERVENTION (Device) Food and Beverage In-kind items and services $23.05 General
Category: VASCULAR
08/22/2018 Ortho Dermatologics, a division of Bausch Health US, LLC JUBLIA (Drug), ELIDEL, ONEXTON Food and Beverage In-kind items and services $34.56 General
Category: PODIATRY
07/19/2018 DUSA Pharmaceuticals, Inc. Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug), BLU-U Blue Light Photodynamic Therapy Illuminator Model 4170 Food and Beverage In-kind items and services $22.55 General
Category: Dermatology
05/28/2018 NOVARTIS PHARMACEUTICALS CORPORATION XOLAIR (Biological) In-kind items and services $837.88 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: RESPIRATORY
05/15/2018 NOVARTIS PHARMACEUTICALS CORPORATION XOLAIR (Biological) In-kind items and services $2,356.25 Research
Study: RESEARCH RELATED PUBLICATION SUPPORT • Category: RESPIRATORY
04/13/2018 Merck Sharp & Dohme Corporation MK-8931 (Drug) Consulting Fee Cash or cash equivalent $487.50 General
Category: NEUROSCIENCE
03/23/2018 Celgene Corporation Otezla (Drug) Food and Beverage In-kind items and services $14.88 General
Category: Dermatology
02/16/2018 Ortho Dermatologics, a division of Bausch Health US, LLC Food and Beverage In-kind items and services $146.04 General

Research Studies & Clinical Trials

Study Name Company Amount Records
RESEARCH RELATED PUBLICATION SUPPORT NOVARTIS PHARMACEUTICALS CORPORATION $7,458 6
CRISABOROLE CLINICAL PUBLICATION PROGRAM PFIZER INC. $330.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 6 100 131 $19,234 $3,616
2021 9 728 1,043 $179,855 $59,816
2020 11 754 1,175 $142,526 $48,999
Total Patients
1,582
Total Services
2,349
Medicare Billing
$112,431
Procedure Codes
26

All Medicare Procedures & Services

26 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 16 19 $4,715 $971.42 20.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 31 33 $5,856 $922.44 15.8%
17110 Destruction of skin growth, 1-14 growths Office 2022 15 16 $3,596 $732.64 20.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 11 11 $2,446 $474.09 19.4%
17000 Destruction of precancer skin growth, 1 growth Office 2022 15 16 $2,149 $367.81 17.1%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 12 36 $473.76 $147.38 31.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 135 203 $50,729 $17,633 34.8%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 185 250 $44,244 $15,090 34.1%
17110 Destruction of up to 14 skin growths Office 2021 79 105 $23,413 $8,242 35.2%
11102 Tangential biopsy of single skin lesion Office 2021 65 71 $14,396 $4,808 33.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 38 38 $12,796 $4,139 32.3%
17000 Destruction of skin growth Office 2021 89 106 $13,862 $3,951 28.5%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 66 66 $14,712 $3,803 25.8%
11104 Punch biopsy of single skin lesion Office 2021 12 13 $3,320 $1,219 36.7%
17003 Destruction of 2-14 skin growths Office 2021 59 191 $2,385 $931.38 39.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 159 209 $31,446 $11,280 35.9%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 117 139 $30,352 $10,491 34.6%
17110 Destruction of up to 14 skin growths Office 2020 70 82 $18,186 $6,609 36.3%
11102 Tangential biopsy of single skin lesion Office 2020 80 80 $15,928 $5,681 35.7%
17000 Destruction of skin growth Office 2020 106 126 $16,461 $4,642 28.2%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 59 59 $12,783 $4,309 33.7%
99202 New patient office or other outpatient visit, typically 20 minutes Office 2020 43 43 $6,565 $2,001 30.5%
17003 Destruction of 2-14 skin growths Office 2020 79 393 $4,622 $1,743 37.7%
11104 Punch biopsy of single skin lesion Office 2020 11 12 $2,999 $1,011 33.7%
11103 Tangential biopsy of additional skin lesion Office 2020 17 18 $1,912 $762.27 39.9%

About Dr. Michael Tharp, MD

Dr. Michael Tharp, MD is a Dermatology healthcare provider based in Brandon, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699785295.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Tharp, MD has received a total of $22,861 in payments from pharmaceutical and medical device companies, with $30.18 received in 2024. These payments were reported across 36 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($13,600).

As a Medicare-enrolled provider, Tharp has provided services to 1,582 Medicare beneficiaries, totaling 2,349 services with total Medicare billing of $112,431. Data is available for 3 years (2020–2022), covering 26 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Brandon, FL
  • Active Since 08/08/2006
  • Last Updated 01/23/2024
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1699785295

Products in Payments

  • XOLAIR (Biological) $7,458
  • COSENTYX (Biological) $5,400
  • Rituxan (Biological) $4,864
  • MK-8931 (Drug) $1,300
  • EUCRISA (Drug) $395.66
  • WATCHMAN Access System (Device) $92.10
  • JUBLIA (Drug) $34.56
  • TREMFYA (Drug) $29.47
  • Humira (Biological) $27.71
  • GENERAL VASCULAR INTERVENTION (Device) $23.05
  • Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% (Drug) $22.55
  • General - Metallic Stents (Device) $19.60
  • ODOMZO (Drug) $16.25
  • Otezla (Drug) $14.88
  • GENERAL - ATHERECTOMY (Device) $14.62
  • SKYRIZI (Biological) $14.62

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Brandon